| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer, Sec | See Remarks
2 companies
Jennifer J Rhodes is See Remarks at ELTX and has filed Form 4s across 2 companies. From February 2021 to March 2026, the filings on record show 0 open-market purchases and 14 sales. Jennifer J Rhodes's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $278K at current prices.
Historically, Jennifer J Rhodes's trades have earned a strong insider score of 93/100 across 13 rated trades. Over a 12-month horizon, all 11 of those trades were profitable, with an average 12-month return of +86.5%.
The biggest single holding is ACAD (~$232K) as EVP, Chief Legal Officer, Sec. The ACAD filings lean toward selling, a net 10,794 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 440 | $13.92 | $6,124.80 | -1.3% | -22.9% | -90.8% | |
| Apr 15, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 399 | $15.01 | $5,988.99 | -1.2% | -28.3% | -88.4% | |
| Mar 13, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 499 | $20.45 | $10,204.55 | -1.4% | -35.5% | -91.7% | |
| Feb 13, 2021 | ELTX Elicio Therapeutics, Inc. | See Remarks | Sell | 457 | $19.54 | $8,929.78 | -1.3% | - | - |